Home / Health / GLP-1 Weight Loss: Costs Diminish Satisfaction
GLP-1 Weight Loss: Costs Diminish Satisfaction
23 May
Summary
- High costs significantly decrease patient satisfaction with GLP-1s.
- Side effects are common, leading many to switch medications.
- Prescription access remains a major challenge for many users.
Several years after their widespread introduction, GLP-1 medications for weight loss have significantly impacted clinical care and public awareness. However, the patient experience is now being defined by factors beyond initial efficacy.
A survey reveals that cost is a primary driver of satisfaction. While coverage fully covering the medication yields high satisfaction, dissatisfaction spikes dramatically for those paying over $1,000 monthly. This highlights how insurance coverage and design increasingly dictate treatment success, not just clinical response.
Side effects, with nausea being the most frequent, are common. These effects often lead to medication changes, with about 31% of those experiencing side effects switching drugs. Furthermore, over a third of patients report difficulty filling prescriptions due to stockouts, pharmacy delays, or insurance issues.
Access challenges persist across various care pathways. While over half of users report improved overall health, the sustainability of GLP-1 treatment depends heavily on the healthcare system's ability to support patients through cost, side effects, and supply chain disruptions.
